Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches

Nephrology Dialysis Transplantation

Volumn 21, Issue 9, 2006, Pages 2485-2490

  Moroni, Gabriella ^a   Gallelli, Beniamina ^a   Banfi, Giovanni ^a   Sandri, Sandro ^b   Messa, Piergiorgio ^a   Ponticelli, Claudio ^c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Divisione di Urologia   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Idiopathic retroperitoneal fibrosis; Immunosuppressive therapy; Renal long term survival; Ureterolysis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; IDIOPATHIC DISEASE; KIDNEY FAILURE; LONG TERM CARE; MALE; NEPHROSTOMY; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RETROPERITONEAL FIBROSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; URETER DISEASE; URETER STENT; COMPARATIVE STUDY; IMPLANTATION; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PERCUTANEOUS NEPHROSTOMY; RETROSPECTIVE STUDY; STENT; TIME; URETER; URETER OBSTRUCTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; AZATHIOPRINE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEPHROSTOMY, PERCUTANEOUS; PROSTHESIS IMPLANTATION; RECURRENCE; RETROPERITONEAL FIBROSIS; RETROSPECTIVE STUDIES; STENTS; TAMOXIFEN; TIME FACTORS; TREATMENT OUTCOME; URETER; URETERAL OBSTRUCTION;

EID: 33750100237     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl228     Document Type: Article

References (21)

1. Gilkeson GS, Allen NB. Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am 1996; 22: 23-38
2. Parum DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low-density lipoprotein and ceroid in the chronic periaortitis. Arch Pathol Lab Med 1990; 114: 383-387
3. Vaglio A, Corradi D, Manetti L et al. Evidence of autoimmunity in chronic periaortitis: A prospective study. Am J Med 2003; 114: 454-462
4. Moroni G, Del Papa N, Moronetti LM et al. Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease. Kidney Int 2005; 68: 562-568
5. Higgins PM, Bennett-Jones DN, Naish PF, Aber GM. Non-operative management of retroperitoneal fibrosis. Br J Surg 1988; 75: 573-577
6. Heidenreich A, Derakhshani P, Neubauer S, Krug B. Treatment outcomes in primary and secondary retroperitoneal fibrosis. Urologe A 2000; 39: 141-148
7. Harreby M, Bilde T, Helin P, Meyhoff HH, Vinterberg H, Nielsen VA. Retroperitoneal fibrosis treated with methylprednisolone pulse and disease-modifying antirheumatic drugs. Scand J Urol Nephrol 1994; 28: 237-242
8. van Bommel EF, van Spengler J, van der Hoven B, Kramer P. Retroperitoneal fibrosis: Report of 12 cases and a review of the literature. Neth J Med 1991; 39: 338-345
9. Marcolongo R, Tavolini IM, Laveder F. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: A retrospective analysis of 26 cases. Am J Med 2004; 116: 194-197
10. Moroni G, Dore R, Collini P. Idiopathic retroperitoneal fibrosis. J Nephrol 2005; 18: 794-808
11. Clark CP, Vanderpool D, Preskitt JT. The response of retroperitoneal fibrosis to tamoxifen. Surgery 1991; 109: 502-506
12. Loffeld RJ, van Weel TF. Tamoxifen for retroperitoneal fibrosis. Lancet 1993; 341: 382
13. Vivas I, Nicolas AI, Velazquez P, Elduayen B, Fernandez-Villa, Martinez-Cuesta A. Retroperitoneal fibrosis: Typical and atypical manifestations. Br J Radiol 2000; 73: 214-222
14. Wagenknecht LV, Hardy JC. Value of various treatments for retroperitoneal fibrosis. Eur Urol 1981; 7: 193-200
15. Baker LRI, Mallison WJW, Gregory MC. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol 1988; 60: 497-503
16. Speziale F, Sbarigia E, Grossi R, Maraglino C, Fiorani P. Inflammatory aneurysm of the abdominal aorta involving the ureters: Is combined treatment really necessary. J Urol 2001; 165: 27-31
17. Tralce L, Antonelli A, Dotti P, Cunico SC. Epidemiology, clinical features and treatment of idiopathic retroperitoneal fibrosis: Our experience. Arch Ital Urol Androl 2004; 76: 135-139
18. Kardar AH, Kattan S, Lindstedt E, Hanash K. Steroid therapy for idiopathic retroperitoneal fibrosis: Dose and duration. J Urol 2002; 168: 550-555
19. Cooksey G, Powell PH, Singh M, Yeates WK. Idiopathic retroperitoneal fibrosis a long-term review after surgical treatment. Br J Urol 1982; 54: 628-631
20. Amis ES Jr. Retroperitoneal fibrosis. AJR 1991; 157: 321-329
21. Tiptaft RC, Costello AJ, Paris AMI, Blandy JP. The long-term follow-up of idiopathic retroperitoneal fibrosis. Br J Urol 1982; 54: 620-624